A Class Action Lawsuit Has Been Filed Against India Globalization Capital, Inc. by Gainey and McKenna & Egleston

Blockchain Expo North America 2019

Gainey McKenna & Egleston announced that a class action lawsuit has been filed against India Globalization Capital, Inc.  The announcement was made in the United States District Court for the Eastern District of New York, on behalf of a class consisting of investors who purchased, or otherwise acquired, India Globalization securities between October 25, 2017 through October 29, 2018.

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: India Globalization’s business model was in a state of change in order to lure potential blockchain and cannabis investors. India Globalization had overstated the benefits of its relationships with manufacturers, partners, and distributors in order to inflate its potential commercial success in the blockchain and cannabis markets. As a result, the New York Stock Exchange de-listed India Globalization’s shares from its exchange. And consequently, Defendants’ statements about India Globalization’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.  When the true details entered the market, the lawsuit claims that investors suffered damages.

advertisementToken Agency

Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm prior to the January 2, 2019 lead plaintiff motion deadline.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Bragar Eagel & Squire, P.C. also reminds investors that class action lawsuits have been commenced on behalf of stockholders of Alnylam Pharmaceuticals, Inc., Acadia Healthcare Company, Inc., and India Globalization Capital, Inc. Stockholders have until the deadlines listed below, to petition the court to serve as lead plaintiff.

Lead Plaintiff Deadline: November 26, 2018 for Alnylam Pharmaceuticals. Lead Plaintiff Deadline: December 3, 2018 for Acadia Healthcare Company, Inc. Lead Plaintiff Deadline: January 2, 2019 for India Globalization Capital, Inc.

Wieke Beenen

About Wieke Beenen

Writing has always been the red thread in my life. In the early 90's I attended the Journalism program at the School for Journalism in Utrecht and later the History and Journalism program at the RUG in Groningen. I spent a number of years working in the Caribbean boating industry as a first mate on several charter boats as well as in the island media writing about culture, flora and fauna. After moving back to the Netherlands I started my own translation business in 2005. After a short detour teaching kids English at several high schools, I'm now back doing what I like best, writing and editing content for Blockchain News.

Visit Website
View All Articles
advertisements Blockchain Partners

Token Agency
Blockchain Expo North America 2019